Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients

Yoojin Noh1 Department of Clinical Pharmacy, College of Pharmacy, Ajou University, Yeongtong-gu, Suwon, Republic of Korea, [email protected]

Sukhyang Lee1 Department of Clinical Pharmacy, College of Pharmacy, Ajou University, Yeongtong-gu, Suwon, Republic of Korea, [email protected];2 Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Yeongtong-gu, Suwon, Republic of Korea, [email protected]

Sooyoung Shin1 Department of Clinical Pharmacy, College of Pharmacy, Ajou University, Yeongtong-gu, Suwon, Republic of Korea, [email protected];2 Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Yeongtong-gu, Suwon, Republic of Korea, [email protected]Correspondence[email protected]

Pages 1563-1571 | Published online: 03 Sep 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Korean Diabetes Association [webpage on the Internet]Korean Treatment Guideline for Diabetes2015 Available from: http://www.diabetes.or.kr/pro/publish/guide.php?mode=listAccessed January 8, 2018
Google Scholar
American Diabetes AssociationStandards of medical care in diabetes-2017Diabetes Care201740suppl 1S1S13227979885
PubMedGoogle Scholar
NohYKangDRKimDJLeeKJLeeSShinSImpact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapiesPharmacoepidemiol Drug Saf201726111338134628771933
PubMed Web of Science ®Google Scholar
Williams-HermanDJohnsonJTengREfficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetesDiabetes Obes Metab201012544245120415693
PubMed Web of Science ®Google Scholar
AschnerPKatzeffHLGuoHSitagliptin Study 049 GroupEfficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetesDiabetes Obes Metab201012325226120070351
PubMed Web of Science ®Google Scholar
ShinSKimHThe effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort studyTher Clin Risk Manag20161243544427042085
PubMed Web of Science ®Google Scholar
KahnSEHaffnerSMHeiseMAADOPT Study GroupGlycemic durability of rosiglitazone, metformin, or glyburide monotherapyN Engl J Med2006355232427244317145742
PubMed Web of Science ®Google Scholar
LambertsEJNijpelsGWelschenLMLong term patterns of use after initiation of oral antidiabetic drug therapyPharmacoepidemiol Drug Saf201120435135821442684
PubMed Web of Science ®Google Scholar
GrimesRTBennettKTilsonLUsherCSmithSMHenmanMCInitial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patientsBr J Clin Pharmacol20157961000100925521800
PubMed Web of Science ®Google Scholar
EkstromNSvenssonAMMiftarajMDurability of oral hypoglycemic agents in drug naive patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR)BMJ Open Diabetes Res Care201531e000059
Google Scholar
SikkaRXiaFAubertREEstimating medication persistency using administrative claims dataAm J Manag Care200511744945716044982
PubMed Web of Science ®Google Scholar
SpreeuwenbergMDBartakACroonMAThe multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental healthMed Care201048216617420068488
PubMed Web of Science ®Google Scholar
InzucchiSELipskaKJMayoHBaileyCJMcGuireDKMetformin in patients with type 2 diabetes and kidney disease: a systematic reviewJAMA2014312242668267525536258
PubMed Web of Science ®Google Scholar
BerkowitzSAKrummeAAAvornJInitial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness studyJAMA Intern Med2014174121955196225347323
PubMed Web of Science ®Google Scholar
PhungOJSchwartzmanEAllenRWEngelSSRajpathakSNSulphonylureas and risk of cardiovascular disease: systematic review and meta-analysisDiabet Med201330101160117123663156
PubMed Web of Science ®Google Scholar
PhungOJScholleJMTalwarMColemanCIEffect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetesJAMA2010303141410141820388897
PubMed Web of Science ®Google Scholar
KungJHenryRRThiazolidinedione safetyExpert Opin Drug Saf201211456557922616948
PubMed Web of Science ®Google Scholar
BennettWLMaruthurNMSinghSComparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinationsAnn Intern Med2011154960261321403054
PubMed Web of Science ®Google Scholar
DavisTMEBeyond metformin: selecting a second therapyMedicographia2016383744
Google Scholar
NathanDMThiazolidinediones for initial treatment of type 2 diabetes?N Engl J Med2006355232477248017145743
PubMed Web of Science ®Google Scholar
MiyazakiYMahankaliAMatsudaMEffect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patientsJ Clin Endocrinol Metab20028762784279112050251
PubMed Web of Science ®Google Scholar
GrantRWPabon-NauLRossKMYouattEJPandiscioJCParkERDiabetes oral medication initiation and intensification: patient views compared with current treatment guidelinesDiabetes Educ2011371788421115980
PubMed Web of Science ®Google Scholar
BrownSEMeltzerDOChinMHHuangESPerceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and non-vulnerable older patientsJ Am Geriatr Soc20085671183119018492034
PubMed Web of Science ®Google Scholar
TohMRTeoVKwanYHRaajSTanSYTanJZAssociation between number of doses per day, number of medications and patient’s non-compliance, and frequency of readmissions in a multi-ethnic Asian populationPrev Med Rep20141434726844038
PubMedGoogle Scholar
WimmerBCDentEBellJSMedication regimen complexity and unplanned hospital readmissions in older peopleAnn Pharmacother20144891120112824867583
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date